SJS/TEN 2019, April 26-27, 2019:

Question & Answer Responses:

Does treating the ADRs from checkpoint inhibitors reduce their anti-cancer efficacy? (Asked by Michele Ramien)

No, it does not. Thank you

(Answered by Mario Lacouture)

Meeting Videos:

Introduction

Panel Discussion Pharmacogenomics And Considerations For Implementation

Day 1, SESSION 1 Racial Disparities

Day 1, SESSION 1 Funding Opportunities in Adverse Drug Reactions & SJS/TEN Pharmacogenomics Research

Day 1, SESSION 2 Clinical Approaches Update on Management

Day 1, SESSION 3 Updates in Global Regulatory Science, Pharmacovigilance and Data Mining

Day 1, SESSION 3 Applications in the Electronic Health Record to Improve Drug Safety

Day 1, SESSION 4 Genomic Approaches for Prediction, Prevention, Treatment - Technologies & Discovery

Day 1, SESSION 5 Special Populations, Challenges and Diagnosis

Day 1, SESSION 6 Update in Ocular Science

Day 1, SESSION 7 Patient and Family Stories